Alixorexton’s Phase II performance sets it up for late-stage success, according to analysts at Truist Securities. Alkermes ...

Discover key insights from Trevi Therapeutics' Q3 2025 earnings call, including clinical progress, strong financials, and upcoming regulatory milestones.

Strategic process -- Formal engagement with Evercore concluded; current focus is on Phase III clinical execution, with ...

FDA Alignment -- BioAtla ( BCAB 4.08%) achieved FDA alignment on phase three trial design, dosing, comparator, and endpoints ...

AnaptysBio plans to advance rosnilimab for RA, with a program update expected in the first half of 2026. Read why ANAB stock ...

EVTL enters final phase of VX4 electric aircraft program with Permit to Fly from UK CAA, marking key step towards certification and commercialization.Vertical Aerospace advances VX4 electric aircraft ...

The New York Spirit of Ireland Gala celebrated Irish creativity and connection, honoring Conan O’Brien and Robert Bradway ...

Onyx Gold Corp. is a Canadian exploration company focused on unlocking district-scale gold opportunities in two of the ...

Participants who successfully complete all phases of the program have their charges dismissed and sealed, giving them a fresh ...

Positive 9-month follow-up data for NDV-01 showed a 92% overall response rate at any time in non-muscle invasive bladder cancer (NMIBC), with favorable overall safety ...

Tens of thousands of African migrants returned home through an EU-funded program that promised post-return assistance, but ...

New platform converts an established lead-generation system into a scalable intake and data monetization engine targeting the ...